| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/20/2007 | WO2007106811A2 Method and composition for treatment of renal disease with antibodies and their equivalents |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007008671A3 Methods for treating fus1 related disorders |
| 09/20/2007 | US20070219216 1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | US20070219182 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators |
| 09/20/2007 | US20070219179 Indole Derivative Having Piperidine Ring |
| 09/20/2007 | CA2645809A1 Peptidomimetic inhibitors of psma, compounds comprising them, and methods of use |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/19/2007 | EP1834960A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 09/19/2007 | EP1834640A2 Kappa opiatagonists for treating bladder diseases |
| 09/19/2007 | EP1834639A1 Remedial agent for fat toxicity |
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1594836B1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1408911B1 Sustained-release therapeutic bioadhesive systems |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1242110B1 Composition for treating prostate cancer |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers |
| 09/19/2007 | CN101039688A Herbal compositions for the prevention or treatment of urinary incontinence and overactive bladder |
| 09/19/2007 | CN101037428A Purification of sesquiterpene lactones A in achillea alpine and anti-tumour cell proliferative activity thereof |
| 09/19/2007 | CN101036765A Externally used medicine for treating anischuria and its preparation method |
| 09/19/2007 | CN101036742A Medicine for treating prostatic disease |
| 09/19/2007 | CN101036729A Biological selenium germanium peptide maggot jujube tea powder for preventing SARS |
| 09/19/2007 | CN101036728A Selenium germanium peptide maggot skin antithrombotic jujube tea powder for curing encephalatrophy radically |
| 09/19/2007 | CN101036727A Selenium germanium peptide jujube tea powder for preventing avian influenza |
| 09/19/2007 | CN101036725A Chinese traditional medicine for treating nephrolithiasis |
| 09/19/2007 | CN101036722A Health-caring food for easing and improving climacteric Syndrome of men and the preparation thereof |
| 09/19/2007 | CN101036713A Shumitong concentrated pill and the method for preparing the same |
| 09/19/2007 | CN101036682A Method for preparing epimedium brevicornum wine |
| 09/19/2007 | CN100338219C Tissue specific expression of retinoblastoma protein |
| 09/19/2007 | CN100338061C Alkyne-aryl phosphodiesterase-4 inhibitors |
| 09/19/2007 | CN100338040C Xanthine oxidase inhibitors |
| 09/19/2007 | CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/19/2007 | CN100337549C Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 09/18/2007 | US7271190 Indazole compounds as β3 adrenoceptor agonist |
| 09/18/2007 | US7271188 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 09/18/2007 | US7271181 Inhibitors of p38 |
| 09/18/2007 | US7271156 Immunostimulatory nucleic acids |
| 09/18/2007 | US7271151 administering to effect phosphate metabolism in a patient; Metastatic-tumor Excreted Phosphaturic-Element (MERE) or "phosphatonin"; treating X-linked rickets and tumour osteomalacia for example |
| 09/18/2007 | US7270839 Process of obtaining thylakoids from photosynthetic organisms; plant fractions obtained from the process; pure thylakoids; and methods of use of thylakoids as ROS scavengers, photo-protectors, biosensors, biofilters and bioreactors |
| 09/18/2007 | CA2417106C Piperazine derivatives |
| 09/18/2007 | CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 09/18/2007 | CA2323809C A method for chemoprevention of prostate cancer |
| 09/18/2007 | CA2243234C 5h-thiazolo[3,2-a]pyrimidine derivatives |
| 09/18/2007 | CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them |
| 09/13/2007 | WO2007102531A1 Pharmaceutical combination |
| 09/13/2007 | WO2007102515A1 Phenylthiazole derivative |
| 09/13/2007 | WO2007102011A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070213401 Pharmaceutical uses for alpha2delta ligands |
| 09/13/2007 | US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes |
| 09/13/2007 | US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders |
| 09/13/2007 | US20070213347 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction |
| 09/13/2007 | US20070212347 Compositions and methods for treating polycystic kidney disease gene |
| 09/13/2007 | US20070212325 Insulin Resistance-Improving Agent |
| 09/13/2007 | CA2646883A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain |
| 09/13/2007 | CA2645018A1 Pharmaceutical combination |
| 09/12/2007 | EP1832599A2 Albumin fusion proteins |
| 09/12/2007 | EP1832590A2 Tri- heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 09/12/2007 | EP1689447A4 Gene transfer for regulating smooth muscle tone |
| 09/12/2007 | EP1395566B1 Tricyclic compounds useful as angiotensin ii agonists |
| 09/12/2007 | EP1303496B1 Pyrimidine derivatives |
| 09/12/2007 | EP1299541B1 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 09/12/2007 | EP1019358B2 3,3-diarylpropylamines , their use and preparation |
| 09/12/2007 | CN101035543A Combination therapies employing vitamin B6 related compounds and ACE inhibitors and uses thereof for the treatment of diabetic disorders |
| 09/12/2007 | CN101035433A Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 09/12/2007 | CN101032608A Chinese traditional medicine to be taken orally for curing urinary tract infection |
| 09/12/2007 | CN101032586A Chinese traditional medicine composition to be taken orally for curing acute cystitis |
| 09/12/2007 | CN101032583A Medicine composition and the preparing method and the content testing method |
| 09/12/2007 | CN101032571A Chinese medicine composition, the preparing method and the quality control method thereof |
| 09/12/2007 | CN101032557A Fupian granulae and the preparing method |
| 09/12/2007 | CN101032554A Medicine for curing frequently encountered disease caused by Huohan toxicum and the preparing method |
| 09/12/2007 | CN101032548A Chinese traditional medicine combination for curing and preventing prostate cancer or preventing prostate phyma |
| 09/12/2007 | CN101032545A Novel purpose of Chinese traditional medicine homonoia riparia |
| 09/12/2007 | CN101032500A Application of centella triterpenes in the preparing of medicine for preventing and curing kidney fibrosis |
| 09/12/2007 | CN101032494A Application of Asiatic Acid in the preparing of medicine for preventing and curing kidney fibrosis |
| 09/12/2007 | CN101032483A Composing of hydantoin ramification for adjusting estrogen receptor activity and application thereof |
| 09/12/2007 | CN101032480A Application of triptolide in the preparing of medicine for curing urinary podocytes glomerulonephritis |
| 09/12/2007 | CN100336556C Chinese medicine for treating nephritis, vrinemia and its manufacturing method |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | CA2310536C Erythropoietin derivatives |
| 09/07/2007 | WO2007100098A1 Multimer of extracellular domain of cell surface functional molecule |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007029156A3 Isoindoledione derivatives as adrenergic receptor antagonists |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |